| Literature DB >> 26050948 |
Morsal Samim1, Ghassan E El-Haddad2, Izaak Quintes Molenaar1, Warner Prevoo3, Maurice A A J van den Bosch4, Abass Alavi5, Marnix G E H Lam6.
Abstract
[(18)F]Fluorodeoxyglucose (FDG) PET is a functional imaging tool that provides metabolic information, which has the potential to detect a lesion before it becomes anatomically apparent. This ability constitutes a strong argument for using FDG-PET/computed tomography (CT) in the management of oncology patients. Many studies have investigated the accuracy of FDG-PET or FDG-PET/CT for these purposes, but with small sample sizes based on retrospective cohorts. This article provides an overview of the role of FDG-PET or FDG-PET/CT in patients with liver malignancies treated by means of surgical resection, ablative therapy, chemoembolization, radioembolization, and brachytherapy, all being liver-directed oncologic interventions.Entities:
Keywords: Chemoembolization; FDG-PET; Imaging; Interventional oncology; Liver; Radioembolization; Radiofrequency ablation; Staging
Mesh：
Substances：
Year: 2014 PMID： 26050948 DOI： 10.1016/j.cpet.2014.07.004
Source DB: PubMed Journal: PET Clin ISSN： 1556-8598